| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.933 | 54.973 | 17.268 | 165.387 | 148.857 | 162.138 | 240.553 | 243.960 | 306.746 | 313.185 |
| Total Income - EUR | 45.933 | 54.973 | 17.268 | 165.387 | 148.857 | 163.821 | 240.553 | 248.242 | 308.304 | 323.331 |
| Total Expenses - EUR | 13.347 | 22.281 | 4.146 | 19.228 | 26.606 | 43.691 | 55.967 | 60.992 | 67.381 | 62.799 |
| Gross Profit/Loss - EUR | 32.586 | 32.692 | 13.121 | 146.159 | 122.252 | 120.130 | 184.585 | 187.250 | 240.923 | 260.532 |
| Net Profit/Loss - EUR | 31.208 | 31.506 | 12.890 | 144.505 | 120.763 | 118.607 | 182.180 | 185.062 | 238.196 | 250.832 |
| Employees | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Andorcristalmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.306 |
| Current Assets | 32.229 | 33.240 | 13.953 | 155.637 | 155.105 | 123.928 | 186.369 | 189.303 | 243.425 | 255.637 |
| Inventories | 1.578 | 4.252 | 3.575 | 3.626 | 3.556 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 128.070 | 0 | 11.010 |
| Cash | 30.652 | 28.988 | 10.378 | 152.011 | 151.549 | 123.928 | 186.369 | 61.233 | 61.478 | 11.429 |
| Shareholders Funds | 31.253 | 31.560 | 12.942 | 144.557 | 120.814 | 118.657 | 182.229 | 185.110 | 238.245 | 250.880 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 977 | 1.680 | 1.011 | 11.080 | 34.291 | 5.271 | 4.140 | 4.193 | 5.180 | 6.063 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Andorcristalmed Srl